PIM
VYGR icon

Plato Investment Management’s Voyager Therapeutics VYGR Stock Holding History

Plato Investment Management’s Portfolio VYGR Stock Details VYGR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-1,449
Closed -$8.25K – 619
2024
Q4 		$8.25K Hold
1,449
– – ﹤0.01% 553
2024
Q3 		$8.47K Hold
1,449
– – ﹤0.01% 504
2024
Q2 		$11.5K Sell
1,449
-2,670
-65% -$22.4K ﹤0.01% 445
2024
Q1 		$38.3K Buy
+4,119
New +$34.8K ﹤0.01% 388

Other funds holding VYGR

AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Plato Investment Management's VYGR Position: Q1 2025 in Review

Plato Investment Management sold out of Voyager Therapeutics (VYGR) in Q1 2025, closing a stake of 1,449 shares — an estimated $8.25K sold.

Plato Investment Management first reported a position in VYGR in Q1 2024 and held it in 4 quarters. The position peaked at $38.3K in Q1 2024. 116 funds tracked by Wall St. Rank hold VYGR as of Q1 2025.

  • Plato Investment Management reported no remaining Voyager Therapeutics position as of Q1 2025 after selling out during the quarter.
  • Plato Investment Management sold 1,449 Voyager Therapeutics shares in Q1 2025, an estimated $8.25K.
  • Plato Investment Management first reported a position in Voyager Therapeutics in Q1 2024 and held it in 4 quarters.
  • Plato Investment Management's Voyager Therapeutics position peaked at $38.3K in Q1 2024.
  • 116 funds tracked by Wall St. Rank held Voyager Therapeutics as of Q1 2025.

Based on Plato Investment Management's 13F filing for Q1 2025, filed 20 May 2025.